Latest news
Eli Lilly (LLY) Reports Strong Q2 Earnings Driven by GLP-1 Drug Demand - GuruFocusGuruFocus · Thu, 06 Aug 2026 10:18:45 GMTBioCryst Pharmaceuticals Reports Strong ORLADEYO Revenue Growth and Positive Net Income for 2026 - MinichartMinichart · Wed, 05 Aug 2026 14:37:00 GMTLLY: Eli Lilly Reports Strong Earnings Boosted by GLP-1 Drug Dem - GuruFocusGuruFocus · Wed, 05 Aug 2026 14:08:31 GMTRoyalty Pharma Reports Strong Q2 2026 Earnings with Growth Guidance Increase - Intellectia AIIntellectia AI · Wed, 05 Aug 2026 00:31:46 GMTAmgen Reports Strong Q2 Drug Sales, Raises Guidance, and Will End Early-Stage Weight-Loss Drug Development - BitgetBitget · Wed, 05 Aug 2026 00:23:49 GMTJazz Pharmaceuticals (NASDAQ:JAZZ) Reports Bullish Q2 CY2026, Guides for Strong Full-Year Sales - StockStoryStockStory · Mon, 03 Aug 2026 21:18:45 GMTSenores Pharmaceuticals Reports Strong Q1 FY27 Growth with Higher Profit - Machine MakerMachine Maker · Tue, 28 Jul 2026 11:36:29 GMT